|
HS Code |
485417 |
| Name | Vitamin K1 |
| Chemical Name | Phylloquinone |
| Molecular Formula | C31H46O2 |
| Molecular Weight | 450.7 g/mol |
| Appearance | Yellow viscous oil |
| Solubility | Fat-soluble |
| Source | Leafy green vegetables |
| Main Function | Essential for blood clotting |
| Absorption Site | Small intestine |
| Storage Site | Liver |
| Recommended Daily Intake | About 90-120 mcg for adults |
| Deficiency Symptoms | Easy bruising, excessive bleeding |
| Common Uses | Supplement, treatment for Vitamin K deficiency |
| Cas Number | 84-80-0 |
| Stability | Sensitive to light and alkaline conditions |
As an accredited Vitamin K1 factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Vitamin K1, 25g, supplied in an amber glass bottle with secure screw cap, labeled with CAS information and safety warnings. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for Vitamin K1: Typically 5,000–7,000 kilograms packed in fiber drums or cartons, securely palletized for export. |
| Shipping | Vitamin K1 should be shipped in tightly sealed containers, protected from light and moisture. It is typically shipped at room temperature, but may require cool conditions for long-term transport. Label the package clearly with the chemical name and ensure compliance with local and international shipping regulations for chemicals. |
| Storage | Vitamin K1 should be stored in a tightly closed, light-resistant container, away from direct sunlight and moisture. Keep it at a controlled room temperature, typically between 15°C and 25°C (59°F to 77°F). Avoid exposure to excessive heat, freezing, or humidity. Ensure the storage area is well-ventilated and out of reach of incompatible substances and unauthorized personnel. |
| Shelf Life | Vitamin K1 typically has a shelf life of 2-3 years when stored in a cool, dry place, protected from light. |
Applications of Vitamin K1 in Industrial ManufacturingVitamin K1 plays an essential role in multiple regulated downstream sectors, particularly in applications where precision formulation, stringent quality assurance, and compliance with safety and pharmacopoeial standards are critical. We supply pharmaceutical-grade material directly to production lines, supporting major international manufacturers in integrating this compound for reliable performance and consistent end-product quality. 1. Pharmaceutical Solid Dosage Form ProductionMajor pharmaceutical companies incorporate Vitamin K1 as an active pharmaceutical ingredient (API) in tablets, capsules, and granules aimed at controlling vitamin K deficiency and supporting coagulation therapies. Our product integrates into blending and granulation steps, requiring careful homogeneity and particle size control to match formulation and bioavailability targets. Strict in-line and post-process quality checks ensure that every batch aligns with drug master file (DMF) and pharmacopoeial standards, supporting regulatory filing in multiple countries. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Injectable Formulation for Hospital-Use DrugsHospital and clinical drug manufacturers rely on our material for sterile injectable ampoule production, used in emergency reversal of anticoagulant overdose and neonatal care. The production requires dissolution in a specific solvent system, followed by sterile filtration and ampoule filling under aseptic conditions, with rigorous endotoxin and particulate testing to meet standards for parenteral safety. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Premix for Livestock and Poultry Feed IndustryFeed integrators and premix producers use our Vitamin K1 as a micro-ingredient in compound feed for broilers, laying hens, and swine to maintain normal blood clotting and enhance animal health under farming stress. Consistent granule size and dispersion are essential for even mixing throughout high-throughput pelleting lines and micro-dosing systems, ensuring reliable performance at scale. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Nutritional Fortification in Infant Formula ManufacturingInfant formula processors utilize Vitamin K1 to comply with regulatory requirements for neonatal nutrition and support normal blood coagulation in formula-fed infants. The material undergoes precise pre-dispersion and controlled addition during liquid or powder formulation, with batch sampling to confirm even distribution and stability throughout shelf life according to food safety protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Oral Liquid Dietary Supplements ManufacturingNutraceutical companies formulate oral liquid supplements with Vitamin K1, enhancing adult and elderly nutrition portfolios. Emulsification and stabilizer selection critically impact clarity, dosing reliability, and flavor masking. Tight quality checks for label-claim verification and shelf stability match demands of modern direct-to-consumer and pharma retail suppliers worldwide. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
6. Food Enrichment in Margarine and Plant-Based SpreadsLarge-scale margarine and non-dairy spread manufacturers fortify their food products with Vitamin K1 to match the nutritional content of traditional dairy butter and meet transparent labeling requirements. The vitamin is heat-stable during short-term processing but sensitive to prolonged light exposure, so incorporation occurs just before final emulsification and packaging. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Vitamin K1 prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every day on the plant floor, we keep a close eye on what leaves our reactor vessels. Vitamin K1, known chemically as phylloquinone or phytonadione, stands out in our portfolio not just for its molecular precision but for its role in health and nutrition across the globe. Over years of manufacturing this compound, our technical team has tracked what truly sets our Vitamin K1 apart. We’ve spent decades observing its function in various formulations and we’ve shaped our production process according to both real-world product feedback and the strictest health industry demands.
Our Vitamin K1 comes in several models—most notably the pure crystalline, oil-based, and emulsion grades. Each form comes out of different technological choices at specific stages of synthesis and purification. For example, crystalline Vitamin K1, often showing a bright yellow powder, reaches up to 98.0% minimum assay by HPLC testing. This gives formulators confidence when blending it for tablets or hard capsules, where stability and accurate dosing matter. Our most in-demand model for food fortification and feed applications is the emulsion, which converts the oily, fat-soluble nature of K1 into dispersions that work better in aqueous bases. Food technologists often use this form to ensure homogenous distribution in beverages, fortified dairy, bakery products, and children’s nutritional powders.
Consistency in color, odor, and solubility has proven critical. Our oil-based Vitamin K1, popular among pharmaceutical manufacturers, uses only refined plant oils as carriers. This model lines up with injectable solutions and soft gelatin capsules that require fast absorption and maximal bioavailability. Over the years, we’ve swapped out various solvents and stabilizers, guided by both government regulations and our own internal research into photostability. Sourcing pure starting materials and designing a clean, solvent-free final wash has helped us avoid cross-contamination risks that sometimes occur in less controlled settings.
Pharmaceutical companies demand certificates for every batch, and our laboratory team routinely runs mass spectrometry and chromatographic analysis to verify purity. The purity level often determines where the batch is headed: injectable and prescription markets require unambiguous quality, while nutritional blends allow for slightly wider specification ranges. Physicians around the world rely on the stability of our vitamin in neonatal injection solutions, where low levels of residual solvents and quick dissolution characteristics directly affect the safety of newborns. Nutraceutical companies use oil dispersions in soft capsules, counting on high clarity and absence of particulate matter. As a manufacturer, we rarely see these distinctions on the outside packaging, but at the loading bay, reviewing orders and regulatory paperwork, we know the right grade is matched to the right market every time.
Animal feed manufacturers approach us with another set of challenges: pellets and powders need flowability and an ability to withstand milling or steam treatment. We found that our emulsion and microencapsulated grades don’t cake in hoppers or feeding lines. This has cut down customer complaints, and feedback loops with feed mills allowed us to troubleshoot past issues with clumping and breakdown during pelleting. With the livestock industry investing in high-return performance foods, our K1 supports healthy growth in young animals and contributes to improved feed conversion, thanks to its role in blood clotting and bone formation.
On the science side, Vitamin K1 distinguishes itself from Vitamin K2 in both molecular structure and physiological function. K1 naturally occurs in leafy greens and is biosynthesized by plants, while K2, or menaquinone, arises from microbial activity in fermented foods. Many in the marketplace, especially supplement growers, blur this distinction or view them as interchangeable. Our experience, from reviewing pharmacopoeial monographs to working with end-user reports, shows clear differences in bioactivity and tissue distribution. Vitamin K1’s fast-acting, direct influence on hepatic blood coagulation differs from the more distributed physiological actions of certain K2 forms on cardiovascular health or calcium metabolism.
In our own labs, the purification and stabilization of K1 require distinct steps. K1 oils are more photolabile compared to their K2 cousins; without effective light shielding from synthesis all the way through packaging, degradation can quickly occur. This is not just theoretical: we have measured and documented loss in potency with improper packing and subpar light protection. To combat this, we switched to fully opaque, nitrogen-flushed containers shortly after first observing sample declines during overseas shipments. In addition, maintaining strict process controls and rapid bottling under inert gas has kept our overall product shelf life above industry averages.
Focusing on trace impurities has required upgrading our analytical capability over time. Our earliest batches from the '90s only relied on thin-layer chromatography, catching major impurities but missing subtle ones. With today’s more advanced LC-MS/MS systems, we spot residual chemical process intermediates or breakdown products that may occur during storage. Eliminating these impurities meant reworking some of our older reactors, shifting to higher-grade stainless steel, and training our staff to run multi-stage filtration during the final step of purification. Because we run our own quality control labs, we catch any issues at the source, and nothing leaves the plant floor without a complete analytical record.
All of these improvements grew out of actual problem-solving: the shift to pharmaceutical grade filtration started when a long-term clinical trial flagged inconsistent results that traced back to minor undetected impurities. It took several months, a full review of process records, and multiple vendor visits to lock in a higher level of product consistency. We’ve seen trust build in our product lines precisely because traceability and record keeping are anchored in the manufacturing workshop, not outsourced to third parties.
Keeping up with health authority requirements is always a moving target. Food and pharmaceutical authorities from different continents do not always agree on allowable impurity profiles or maximum solvent residues. For instance, after the European Pharmacopoeia updated its threshold on ethyl acetate residues, we redesigned a part of our distillation protocol to bring all future batches below stricter limits. Our in-house toxicology review panel, made up of staff chemists and former regulatory inspectors, helps steer these changes. They review new raw material supplier records, monitor trace allergen contents, and sign off on packaging upgrades before they reach the end user.
Customers from the infant formula sector often approach us with questions about allergens and genetically modified origins. Our sourcing policy rules out genetically modified starting materials, and as manufacturers, we are able to provide full-chain documentation on every input. We also routinely conduct allergen panel screening to rule out traces from cross-contact with soy, peanut, or gluten materials. We take particular pride in this work, since regulatory audits become less stressful for our clients—over the last decade, routine documentation and transparent records have become our strongest call card in the international market.
Vitamin K1 transport involves another layer of complexity. Rising temperatures during transshipment in summer have challenged product stability, especially where local logistics lack cold chain infrastructure. We have responded by improving insulation on finished goods and tracking shipment routes more closely. When major heat waves hit, our logistics team worked with customers to stagger shipments and use faster, direct transport routes. This kind of problem-solving only happens with hands-on involvement—it cannot be delegated to remote consultants or brokers.
Costs on the Vitamin K1 production line have risen sharply with global supply chain disruptions, tighter energy markets, and raw material fluctuations. We faced a tough decision whether to trim quality measures to save costs or hold to our established standards. The company sided with long-term brand reputation. By holding our own analytical verification process firmly in place, we avoid the pitfall of batch-to-batch inconsistencies that sometimes show up in peer products when margin pressure mounts. End-users notice stability; we have received direct feedback from customers running stability trials who compare our product's year-over-year results against generic competitors’ slippage.
Some industry trends, such as plant-based and vegan product labeling, have caused a spike in demand for non-animal origin inputs. Our Vitamin K1 is synthesized only from plant-derived raw materials, and we document source and process for every lot. Competitors, chasing lower costs, occasionally blend ingredients or cut corners with synthetic analogs that do not match our product’s molecular profile. Over time, healthcare professionals report greater confidence in products with clear, documented origin—a view echoed in repeated orders and reduced return rates.
Users who blend our Vitamin K1 often share insights that never make it into regulatory filings. Production managers at supplement factories describe smooth blending and consistent performance across major production runs. A few years back, a beverage company experiencing settling issues traced the problem to an off-spec K1 emulsion from another supplier; switching to our consistent droplet size cut down precipitation and shelf-life complaints. We get our share of troubleshooting calls, but open communication means we rapidly adjust specs or send technical support to the product line. This informal back-and-forth sharpens our own processes—direct user feedback is often more revealing than formal complaints.
Small manufacturers and contract packagers, especially those entering the growing personalized supplement market, turn to us for practical formulation advice. Our technical team has learned through repeated trials exactly where dispersions succeed and fail. Water-dispersible grades—hard-won through multiple test batches—reduce clumping in powdered drink mixes and facilitate even dosing in sachets or single-serve stick packs. We know that seemingly minor process variables, such as shear rates in blending, have outsized influence on product performance. Every adjustment we recommend comes from actual floor experience, not theoretical modeling.
Years back, manufacturing chemicals often meant ignoring process waste and energy use. Today, one priority sits at every daily team meeting: driving waste minimization and safe chemical handling. Vitamin K1 production produces small quantities of solvent waste; our solvents, such as methanol and ethanol, are now recovered through closed-loop systems. Teams track and record solvent inputs and outputs every batch, reporting monthly to our internal sustainability team. This close attention to every waste stream has stretched us but also uncovered new efficiencies. Disposal costs dropped once we put recovery measures in place, and regulatory audits on environmental impact show consistent year-over-year improvement.
Bio-based packaging has moved from an afterthought to a key part of our supply chain decisions. Thanks to partnerships with innovative materials companies, all finished Vitamin K1 goods now ship in post-consumer recycled drums or recyclable glass, aligning commercial needs with environmental stewardship. Every product label tells this story, but employee pride at seeing old process drums turned into new packaging runs deeper. Customers consistently express support for this evolution, making our long-term green investments worthwhile.
Vitamin K1’s importance takes on life-and-death consequences for specific groups: newborns needing routine supplementation, those managing warfarin therapy, and patients confronting rare bleeding disorders. As manufacturers, we understand that even small inconsistencies can have immediate effects. Our legacy includes partnering with clinicians who documented real-world failings of less reliable sources, sometimes leading to product recalls. Learning from these events, we place error prevention at the center of every batch—and this vigilance sits at the core of trust with every healthcare partner.
Speaking with frontline clinicians, we hear about situations where precise dose response differences between K1 and other vitamins matter—even down to microgram levels. We use these facts to recalibrate our in-process controls, recognizing that patient safety means close scrutiny of every potential variable. No number printed on a specification sheet quite captures what a mother or a doctor faces, trusting in the unseen quality in every milliliter or milligram of the finished product.
Challenges never slow down. Supply chain volatility, new regulatory frameworks, and scientific advances all push us forward. Our R&D line focuses on improving the solubility of Vitamin K1 in clear functional beverages and on new encapsulation technologies to prolong shelf life even in hot, humid climates. Our collaborations with university researchers test how K1 interacts with plant proteins and novel matrix carriers, aiming for new product categories that address consumer preferences for clean labels and improved stability.
Having watched the Vitamin K1 sector for decades, we have learned that every tweak in process, every material change, and every quality check has ripple effects. The trust we build with our partners depends on transparency, willingness to address problems early, and relentless attention to detail. In an era crowded with new entrants and rapidly changing standards, long-term manufacturer experience grounds our work—blending scientific rigor with hands-on problem solving, batch after batch.